149 related articles for article (PubMed ID: 38288475)
1. Case report: Early molecular confirmation and sodium polystyrene sulfonate management of systemic pseudohypoaldosteronism type I.
Alkhatib EH; Bartlett D; Kanakatti Shankar R; Regier D; Merchant N
Front Endocrinol (Lausanne); 2023; 14():1297335. PubMed ID: 38288475
[TBL] [Abstract][Full Text] [Related]
2. Salt-Losing Syndrome in a Girl with Type I and II Pseudohypoaldosteronism.
Szmigielska A
Am J Case Rep; 2022 Oct; 23():e937536. PubMed ID: 36303414
[TBL] [Abstract][Full Text] [Related]
3. [Multiple type I pseudohypoaldosteronism: neonatal management and outcome].
Cristina De Frutos Martínez M; Elorza Martínez M; Salas Hernández S; García Sánchez P; Jaso Cortés E; Pérez-Rodríguez J; Quero Jiménez J
An Esp Pediatr; 2000 Jan; 52(1):47-51. PubMed ID: 11003859
[TBL] [Abstract][Full Text] [Related]
4. [Neonatal systemic pseudohypoaldosteronism type I].
Cao XC; Chen YY; Zhang K; Zhang XJ; Yang L; Li ZH
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jul; 25(7):774-778. PubMed ID: 37529962
[TBL] [Abstract][Full Text] [Related]
5. Clinical Management in Systemic Type Pseudohypoaldosteronism Due to
Karacan Küçükali G; Çetinkaya S; Tunç G; Oğuz MM; Çelik N; Akkaş KY; Şenel S; Güleray Lafcı N; Savaş Erdeve Ş
J Clin Res Pediatr Endocrinol; 2021 Nov; 13(4):446-451. PubMed ID: 32840096
[TBL] [Abstract][Full Text] [Related]
6. Critical points in the management of pseudohypoaldosteronism type 1.
Güran T; Değirmenci S; Bulut İK; Say A; Riepe FG; Güran Ö
J Clin Res Pediatr Endocrinol; 2011; 3(2):98-100. PubMed ID: 21750640
[TBL] [Abstract][Full Text] [Related]
7. Life threatening hyperkalemia in a neonate with pseudo-hypoaldosteronism.
Choudhry S; Najam Y
J Pak Med Assoc; 2012 Mar; 62(3):287-8. PubMed ID: 22764468
[TBL] [Abstract][Full Text] [Related]
8. Pseudohypoaldosteronism type 1: management issues.
Sharma R; Pandey M; Kanwal SK; Zennaro MC
Indian Pediatr; 2013 Mar; 50(3):331-3. PubMed ID: 23680607
[TBL] [Abstract][Full Text] [Related]
9. Pseudohypoaldosteronism type-I: a rare cause of hyperkalemia in neonates.
Bangash AS; Ali NF; Sami S; Iqbal M
J Pak Med Assoc; 2014 Apr; 64(4):484-6. PubMed ID: 24864655
[TBL] [Abstract][Full Text] [Related]
10. Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town.
Serra G; Antona V; D'Alessandro MM; Maggio MC; Verde V; Corsello G
Ital J Pediatr; 2021 Jun; 47(1):138. PubMed ID: 34134742
[TBL] [Abstract][Full Text] [Related]
11. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects.
Hanukoglu A
J Clin Endocrinol Metab; 1991 Nov; 73(5):936-44. PubMed ID: 1939532
[TBL] [Abstract][Full Text] [Related]
12. Pseudohypoaldosteronism: mineralocorticoid unresponsiveness syndrome.
Jaruratanasirikul S; Janjindamai W
J Med Assoc Thai; 2000 Aug; 83(8):948-52. PubMed ID: 10998851
[TBL] [Abstract][Full Text] [Related]
13. Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.
Schweiger B; Moriarty MW; Cadnapaphornchai MA
Curr Opin Pediatr; 2009 Apr; 21(2):269-71. PubMed ID: 19657313
[TBL] [Abstract][Full Text] [Related]
14. Pseudohypoaldosteronism type 1: clinical features and management in infancy.
Amin N; Alvi NS; Barth JH; Field HP; Finlay E; Tyerman K; Frazer S; Savill G; Wright NP; Makaya T; Mushtaq T
Endocrinol Diabetes Metab Case Rep; 2013; 2013():130010. PubMed ID: 24616761
[TBL] [Abstract][Full Text] [Related]
15. Pseudohypoaldosteronism Type II: A Young Girl Presented with Hypertension, Hyperkalemia and Metabolic Acidosis.
Sethar GH; Almoghawi A; Khan N; Altourah W; Ashour NM
J Coll Physicians Surg Pak; 2018 Mar; 28(3):S21-S22. PubMed ID: 29482694
[TBL] [Abstract][Full Text] [Related]
16. Challenges of Diagnosing Pseudohypoaldosteronism (PHA) in an Infant.
Babar GS; Tariq M
Case Rep Endocrinol; 2022; 2022():9921003. PubMed ID: 35859812
[No Abstract] [Full Text] [Related]
17. Severe pseudohypoaldosteronism in a pair of twins not associated with hydramnios.
Bistritzer T; Lahat E; Eshel G; Barr J; Hanukoglu A; Aladjem M
Pediatr Nephrol; 1996 Aug; 10(4):438-41. PubMed ID: 8865238
[TBL] [Abstract][Full Text] [Related]
18. The enigma of pseudohypoaldosteronism.
Zennaro MC; Borensztein P; Soubrier F; Armanini D; Corvol P
Steroids; 1994 Feb; 59(2):96-9. PubMed ID: 8191555
[TBL] [Abstract][Full Text] [Related]
19. Transient pseudohypoaldosteronism: a potentially severe condition affecting infants with urinary tract malformation.
Delforge X; Kongolo G; Cauliez A; Braun K; Haraux E; Buisson P
J Pediatr Urol; 2019 May; 15(3):265.e1-265.e7. PubMed ID: 30962012
[TBL] [Abstract][Full Text] [Related]
20. Systemic Pseudohypoaldosteronism Type 1 due to 3 Novel Mutations in SCNN1Aand SCNN1BGenes.
Cayir A; Demirelli Y; Yildiz D; Kahveci H; Yarali O; Kurnaz E; Vuralli D; Demirbilek H
Horm Res Paediatr; 2019; 91(3):175-185. PubMed ID: 31018202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
